NCT06431776Phase 3Recruiting

Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).

Study sponsor: Savara Inc. · SVRA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-06Estimated
Enrollment · participants5Estimated
Source updated2026-02-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Jan 2027. After: Jun 2027.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source